Skip to content
Screener

Immunome IMNM Prepaid & Other Current

Prepaid & Other Current at other companies

Summit Therapeutics logo
Summit TherapeuticsSMMT
$17.55M+92.5%
CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$4.46M-4.3%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$20.44M+81.2%
Gilead Sciences logo
Gilead SciencesGILD
$3.76B+29.7%
Moderna logo
ModernaMRNA
$124M-83.8%
Omeros logo
OmerosOMER
$7.35M-1.6%

Other financials

Income statement

See full
Revenue--100%
Operating income-$59.3M-32.9%
Net income-$53.8M-29.3%
EPS (diluted)-$0.48+7.7%

Balance sheet

See full
Cash & equivalents$582.7M+126%
Total debt$3.7M-22.6%
Total equity$588.7M+91.7%
Total assets$619.8M+80.9%

Cash flow

See full
Operating cash flow-$58.6M-10.5%
CapEx$3.0M-18.1%
Free cash flow-$61.6M-8.7%

Valuation

See full
Market cap$2.83B+237%
Enterprise value$2.26B+222%
P/S706×+639×

Profitability

See full
Operating margin-5,947.9%-12,002pp
Net margin-5,593.8%-11,284pp
FCF margin-5,118.9%-8,601pp

Returns & leverage

See full
Return on equity-50.1%-10.8pp
Debt / equity0.0×
Current ratio21.7×+11.2×

Where this comes from

Reported directly by Immunome in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Immunome’s 10-Q, filed May 12, 2026.

Filed
May 12, 2026, 4:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-219425
Line itemMarch 31, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$582,693$653,482
Prepaid expenses and other current assets11,6167,295
Total current assets594,309660,777
Property and equipment, net17,08114,636
Operating right-of-use assets2,8282,978
Restricted cash210210

Item 1. Financial Statements.

FAQ

What is Immunome's prepaid & other current?
Immunome (IMNM) reported prepaid & other current of $11.62M in Q1 2026.
How has Immunome's prepaid & other current changed year-over-year?
Immunome's prepaid & other current increased by 100.0% year-over-year, from $5.81M to $11.62M.
What is the long-term trend for Immunome's prepaid & other current?
Over 4 years (2021 to 2025), Immunome's prepaid & other current has grown at a 10.2% compound annual growth rate (CAGR), from $20.17M to $29.78M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Immunome's prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude